Cooperative, nanoparticle-enabled thermal therapy of breast cancer. - Wikidata - wikimedia - TriplyDB

Cooperative, nanoparticle-enabled thermal therapy of breast cancer.

Cooperative, nanoparticle-enabled thermal therapy of breast cancer.

http://www.wikidata.org/entity/Q34489386

about

Strategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and market Safety of Nanoparticles in Medicine Nanoparticles for imaging: top or flop?Evaluation of cell function upon nanovector internalization.Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions Bone marrow endothelium-targeted therapeutics for metastatic breast cancer The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulation A portrait of nanomedicine and its bioethical implications.Applications of zero-valent silicon nanostructures in biomedicine.Small interfering RNA-based molecular therapy of cancers Cancer theranostics with gold nanoshells.Optical heating and temperature determination of core-shell gold nanoparticles and single-walled carbon nanotube microparticles.Hybridized doxorubicin-Au nanospheres exhibit enhanced near-infrared surface plasmon absorption for photothermal therapy applications.Low molecular weight polyethylenimine-conjugated gold nanospheres: a platform for selective gene therapy controlled by near-infrared light.Multistage vector (MSV) therapeutics.Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery.Short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors.Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers.Nanovector delivery of siRNA for cancer therapy Polycation-functionalized nanoporous silicon particles for gene silencing on breast cancer cells.Multistage vectored siRNA targeting ataxia-telangiectasia mutated for breast cancer therapy.An injectable nanoparticle generator enhances delivery of cancer therapeutics.High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics.Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications Nanodiamonds and silicon quantum dots: ultrastable and biocompatible luminescent nanoprobes for long-term bioimaging.Silicon nanostructures for cancer diagnosis and therapy.E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis.Post-nano strategies for drug delivery: Multistage porous silicon microvectors.A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells.Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics.Hippocrates, healing, and healthcare materials.

P2860

Q27015050-21246936-1F67-48A3-B594-8D94412A3CB0 Q28083076-83DBEA86-8BC3-4914-8109-E44C3B13ADE9 Q30429119-6146F8BD-1E65-4F4C-8191-27F35D354378 Q30542151-EE9A20CE-A228-4665-9B43-78AF3E9CEFA2 Q30543404-CFEDD94B-0E93-4167-833C-75287E5BA528 Q33943576-3E25F4CB-52C4-4F99-AD8C-1A4CDED718EB Q34270352-DC0B5FC5-29B7-454D-AEA7-E359C56FE4B5 Q34320889-6AD8FA02-4A5F-4D9B-8DD0-A48C6BF3D3BF Q34490443-ABBA681F-7708-44CA-9176-291D43FEC86B Q34552948-279664D4-40E5-4EB1-B98C-88F64ADA70EC Q35364515-2891719D-7289-4EAF-AD62-E20384E9256B Q35390294-FB5958F8-9044-43A2-B967-ABF8F2532FA5 Q35574749-2658C34D-6C69-4131-9B35-96A5E4A8619E Q36274436-29684A52-BCCE-4334-B8B3-00D1BBB149ED Q36307634-056BD623-147B-46A4-84AE-8A723D6F739D Q36745501-4D900CC9-96AF-4851-B439-DE4F38022BF9 Q36999091-D18D1BBA-1234-4EC8-B206-2C5F042B7B6B Q37187922-E5D88103-0BFF-40CC-875E-0F87A9E44CE7 Q37347097-8ADFC03E-B5B9-4CB9-86DC-314C53766C8E Q37347118-1468141F-5E27-401E-8567-46B5BE5882D0 Q37347130-A5A7BFA2-DABC-4DEF-962A-A2E104E6454B Q37351049-7EEAC049-1EC0-4933-858B-5DE7E0F85D3D Q37404528-1F0F13F2-793B-4089-AFD8-D84020009FCA Q37609544-7EAC6A5F-8D3C-4275-80B6-A3D1129A8FFC Q38519493-E130DF5C-24DA-40C5-975B-C8BDD030373B Q38541957-736EDE71-243D-44AD-A334-E2F4AE0AD52C Q38858690-B5B9AB85-E20F-407B-ADE6-AA9BEE6B2F6A Q39410383-7FA18006-B082-4FEB-B5E0-C4AACE904635 Q41112245-1EA2959B-9ABF-4C6C-90A5-EDF8FB6A2204 Q42068139-EFBDEF0A-4CD9-454A-815C-4F0655202F20 Q45374978-4C7F9171-B3A7-47F1-A3C6-AF6BB2BE31C9

P2860

Cooperative, nanoparticle-enabled thermal therapy of breast cancer.

http://www.wikidata.org/entity/Q34489386

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cooperative, nanoparticle-enabled thermal therapy of breast cancer.

@ast

Cooperative, nanoparticle-enabled thermal therapy of breast cancer.

@en

Cooperative, nanoparticle-enabled thermal therapy of breast cancer.

@nl

type

label

Cooperative, nanoparticle-enabled thermal therapy of breast cancer.

@ast

Cooperative, nanoparticle-enabled thermal therapy of breast cancer.

@en

Cooperative, nanoparticle-enabled thermal therapy of breast cancer.

@nl

prefLabel

Cooperative, nanoparticle-enabled thermal therapy of breast cancer.

@ast

Cooperative, nanoparticle-enabled thermal therapy of breast cancer.

@en

Cooperative, nanoparticle-enabled thermal therapy of breast cancer.

@nl

P1433

Q34489386-4DDAF223-A681-4E3F-B1B3-3E31C2900AD8

P1476

Q34489386-BF6BF4C3-B2B6-42BF-A9FA-26AEE74013CE

P2093

Q34489386-0E7E6810-4C10-4D0E-9614-D7BF23F04C23

Q34489386-11302144-1C7F-46F9-ACFB-63525D0F6838

Q34489386-1AD54F77-1A67-444E-B424-C783694DA8B4

Q34489386-1BC21643-67EA-4070-9A79-4369E50B62A6

Q34489386-403DC319-4C2C-483C-994B-0A5C7180429D

Q34489386-463D6644-12A1-4218-982D-88AF0C6BAF10

Q34489386-7A406A5B-E5D3-4280-833C-E224680D195E

Q34489386-9B844E48-B9CD-4ED9-98CF-B5FB00B9E995

Q34489386-9CCDDBC5-4944-469E-A10C-694688792BC1

Q34489386-BC6C09DE-1BE7-4D43-98A6-114F8D68D332

P2860

Q34489386-054E4D42-2369-4A86-890A-48844AC2DB47

Q34489386-0581BDF1-481F-42DB-A628-E3EBC2B9A693

Q34489386-070E34CA-DAB8-4DD4-A72A-3E5CE954DB7F

Q34489386-0CDEE987-0343-441E-88F0-DBEB9CB5A48A

Q34489386-0DD3DF89-7840-424E-8F19-8EDF57D5801C

Q34489386-1C7F0C73-0601-4299-B78F-F5AC9A082455

Q34489386-29C12678-9ED7-4571-9539-8F061CA862DF

Q34489386-3B8ECA25-E25B-4216-84A9-4174C85D2E90

Q34489386-3CEC6036-6F36-477A-84AE-543C724EA1C5

Q34489386-53628BF6-AE07-460A-8DDB-FF0216ED0F42

P304

Q34489386-F4570ADB-04AB-427F-B08D-993FAC4F56F2

P31

Q34489386-93EBC019-FC34-4CFB-AA21-68DC671B03A0

P356

Q34489386-EDB65D68-0BC4-4CBA-8938-0EF4BF2F59A0

P433

Q34489386-4D46A2CF-A1B9-4FF0-BC60-5AB39CCA7086

P478

Q34489386-4FC81F5E-44E4-4CE9-AA9C-E0132197F822

P577

Q34489386-2EC76591-2C1C-4B50-8874-530E358F9928

P5875

Q34489386-D1254D61-A897-4529-93A8-F0AED53C884B

P698

Q34489386-6628F41A-FDBF-44A1-8A11-C16579883F33

P921

Q34489386-9F9514CA-948C-408E-B0BD-3A2B0BE30659

P932

Q34489386-D20AEA14-7D1A-4897-8582-B39C5A2EF342

P356

P1433

Advanced Healthcare Materials

P1476

Cooperative, nanoparticle-enabled thermal therapy of breast cancer.

@en

P2093

Arturas Ziemys

http://www.w3.org/2001/XMLSchema#string

Chun Li

http://www.w3.org/2001/XMLSchema#string

Donald R Erm

http://www.w3.org/2001/XMLSchema#string

Guodong Zhang

http://www.w3.org/2001/XMLSchema#string

Haifa Shen

http://www.w3.org/2001/XMLSchema#string

Jian You

http://www.w3.org/2001/XMLSchema#string

Litao Bai

http://www.w3.org/2001/XMLSchema#string

Mauro Ferrari

http://www.w3.org/2001/XMLSchema#string

Qingpo Li

http://www.w3.org/2001/XMLSchema#string

Xiaoyong Deng

http://www.w3.org/2001/XMLSchema#string

P2860

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

An integrated genomic analysis of human glioblastoma multiforme

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Cancer statistics, 2010

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

The genomic landscapes of human breast and colorectal cancers

P304

84-89

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ADHM.201100005

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233774871

http://www.w3.org/2001/XMLSchema#string

P698

23184690

http://www.w3.org/2001/XMLSchema#string

P921

P932

3842222

http://www.w3.org/2001/XMLSchema#string